dinaciclib

tumor protein p53 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32934219 CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells. 2020 Sep 15 1
2 30405800 Low dose dinaciclib enhances doxorubicin-induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways. 2018 Nov 1
3 23527225 The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling. 2013 4